Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 3
2012 3
2013 1
2014 1
2015 4
2016 4
2019 4
2020 3
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Barras D, Ghisoni E, Chiffelle J, Orcurto A, Dagher J, Fahr N, Benedetti F, Crespo I, Grimm AJ, Morotti M, Zimmermann S, Duran R, Imbimbo M, de Olza MO, Navarro B, Homicsko K, Bobisse S, Labes D, Tsourti Z, Andriakopoulou C, Herrera F, Pétremand R, Dummer R, Berthod G, Kraemer AI, Huber F, Thevenet J, Bassani-Sternberg M, Schaefer N, Prior JO, Matter M, Aedo V, Dromain C, Corria-Osorio J, Tissot S, Kandalaft LE, Gottardo R, Pittet M, Sempoux C, Michielin O, Dafni U, Trueb L, Harari A, Laniti DD, Coukos G. Barras D, et al. Among authors: berthod g. Sci Immunol. 2024 Feb 2;9(92):eadg7995. doi: 10.1126/sciimmunol.adg7995. Epub 2024 Feb 2. Sci Immunol. 2024. PMID: 38306416
[Locally advanced and metastatic melanoma : novelties].
Huber A, Latifyan S, Nikolopoulou A, Homicsko K, Berthod G, Michielin O, Özdemir BC. Huber A, et al. Among authors: berthod g. Rev Med Suisse. 2020 May 27;16(695):1092-1097. Rev Med Suisse. 2020. PMID: 32462837 Review. French.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Sibon D, Bisig B, Bonnet C, Poullot E, Bachy E, Cavalieri D, Fataccioli V, Bregnard C, Drieux F, Bruneau J, Lemonnier F, Dupuy A, Bossard C, Parrens M, Bouabdallah K, Ketterer N, Berthod G, Cairoli A, Damaj G, Tournilhac O, Jais JP, Gaulard P, De Leval L. Sibon D, et al. Among authors: berthod g. Haematologica. 2023 Jun 1;108(6):1590-1603. doi: 10.3324/haematol.2022.281442. Haematologica. 2023. PMID: 36453105 Free PMC article.
[PARP inhibitors - A better selection of patients].
Senglet M, Berthod G, Courtes MG, Anchisi S, Membrez V, Nay Fellay C. Senglet M, et al. Among authors: berthod g. Rev Med Suisse. 2023 May 17;19(827):932-937. doi: 10.53738/REVMED.2023.19.827.932. Rev Med Suisse. 2023. PMID: 37195105 French.
[Renal carcinoma: what therapeutic options in 2024?].
Klecka M, Rodrigues B, Berthod G, Gobin N. Klecka M, et al. Among authors: berthod g. Rev Med Suisse. 2024 Feb 7;20(860):305-310. doi: 10.53738/REVMED.2024.20.860.305. Rev Med Suisse. 2024. PMID: 38323766 French.
Solitary choriocarcinoma in the lung.
Berthod G, Bouzourene H, Pachinger C, Peters S. Berthod G, et al. J Thorac Oncol. 2010 Apr;5(4):574-5. doi: 10.1097/JTO.0b013e3181cbf372. J Thorac Oncol. 2010. PMID: 20357625 Free article. No abstract available.
26 results